Mylotarg (Gemtuzumab Ozogamicin) - Hospitalization - Suspected Cause - Side Effect Reports

Possible Mylotarg side effects in 66 year old male

Reported by a physician from United Kingdom on 2012-08-17

Patient: 66 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Multi-Organ Failure, Neutropenic Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Mylotarg
    Dosage: 5.3 mg (total dose)
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Possible Mylotarg side effects in 66 year old male

Reported by a physician from United Kingdom on 2012-06-29

Patient: 66 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Multi-Organ Failure, Neutropenic Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Mylotarg
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Possible Mylotarg side effects in 66 year old male

Reported by a physician from United Kingdom on 2012-06-18

Patient: 66 year old male

Reactions: Multi-Organ Failure, Neutropenic Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Possible Mylotarg side effects in 56 year old female

Reported by a physician from United States on 2012-06-11

Patient: 56 year old female, weighing 60.9 kg (133.9 pounds)

Reactions: Acute Myeloid Leukaemia, Supraventricular Tachycardia, Pneumothorax, Pyrexia, Pneumonitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-07
    End date: 2011-11-13

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-11-10
    End date: 2011-11-10

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-11-07
    End date: 2011-11-13

Other drugs received by patient: Metoprolol Tartrate; Oxycodone HCL; Docusate; Ipratropium Bromide; Metoclopramide; Vitamin D; Lanolin; Benadryl; Benadryl; Senna-Mint WAF; Fluconazole; Levofloxacin; Omeprazole; Aluminum-Magnesium-Simethicone; Prochlorperazine; Zofran; Acyclovir; Ascorbic Acid; Hypromellose; Loperamide; Lorazepam; Magnesium Hydroxide TAB; Dalteparin Sodium; Acetaminophen; Lorazepam; Magnesium Citrate; Multi-Vitamins; Miralax; Albuterol; Chlorhexidine Gluconate; Prednisone TAB; Morphine; Eucerin

Possible Mylotarg side effects in 74 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: 74 year old male

Reactions: Diarrhoea, Dehydration, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
CAP Vorinostat UNK
    Dosage: 400 mg/daily/po
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-19
    End date: 2011-10-24

Mylotarg
    Dosage: 3 mg/m[2]//sc, 3 mg/m[2]/iv
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-19

Mylotarg
    Dosage: 3 mg/m[2]//sc, 3 mg/m[2]/iv
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-25

Vidaza
    Dosage: 75 mg/m[2]/daily/sc, 75 mg/m[2]/daily/sc
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-25

Vidaza
    Dosage: 75 mg/m[2]/daily/sc, 75 mg/m[2]/daily/sc
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-19

Possible Mylotarg side effects in female

Reported by a physician from United States on 2012-06-04

Patient: female, weighing 64.9 kg (142.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Febrile Neutropenia, Disease Progression, Cardiac Failure, Injection Site Reaction, Sepsis, Pleural Effusion, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-04
    End date: 2011-11-12

Vidaza
    Dosage: 125 milligram/sq. meter
    Start date: 2011-11-04
    End date: 2011-11-10

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-10

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-10-04
    End date: 2011-10-12

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-11

Mylotarg
    Dosage: 5.1 milligram
    Start date: 2011-11-07
    End date: 2011-11-11

Other drugs received by patient: Levothyroxine Sodium; Diphenhydramine HCL; Lipitor; Hydrocodone

Possible Mylotarg side effects in 66 year old male

Reported by a physician from United Kingdom on 2012-06-01

Patient: 66 year old male

Reactions: Multi-Organ Failure, Neutropenic Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Mylotarg
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Possible Mylotarg side effects in 66 year old male

Reported by a physician from United Kingdom on 2012-05-29

Patient: 66 year old male

Reactions: Multi-Organ Failure, Neutropenic Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-09-20
    End date: 2007-09-22

Possible Mylotarg side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-25

Patient: 61 year old female

Reactions: Pancytopenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Daunorubicin HCL
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-03-14
    End date: 2007-03-18

Evoltra (Clofarabine) Solution FOR Infusion
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-03-14
    End date: 2007-03-18

Mylotarg
    Indication: Acute Myeloid Leukaemia
    Start date: 2007-03-14
    End date: 2007-03-18

Other drugs received by patient: Lorazepam; Loperamide; Oral Balance (Xylitol, Potassium Thiocyanate, Glucose Oxidase, Lysozym; Combivent Nebulizer; Itraconazole; Phosphate Sandoz; Chlorhexidine Gluconate; Vancomycin; Amphotericin B; Cotrim; Combivent Nebuliser; Omeprazole; Potassium Chloride; Phosphate Sandoz; Alimemazine Tartrate; Meropenem; Caspofungin Acetate; Teicoplanin; Calcium Gluconate; Acyclovir; Chlorpheniramine Maleate; Clobestasol Propionate; G-CSF (Granulocyte Colony Stimulating Factor); Calcium Carbonate

Possible Mylotarg side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-16

Patient: 66 year old female, weighing 64.9 kg (142.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Cardiac Failure, Injection Site Reaction, Pleural Effusion, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-11

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-04
    End date: 2011-11-12

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-10

Mylotarg
    End date: 2011-11-11

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-10-04
    End date: 2011-10-12

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-11-04

Other drugs received by patient: Hydrocodone; Lipitor; Diphenhydramine HCL; Levothyroxine Sodium

Possible Mylotarg side effects in male

Reported by a physician from United States on 2012-04-13

Patient: male, weighing 104.6 kg (230.1 pounds)

Reactions: White Blood Cell Count Decreased, Adverse Drug Reaction, Pyrexia, Perirectal Abscess, Device Related Infection, Faeces Hard, Soft Tissue Infection, Anorectal Infection Bacterial

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vorinostat
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-10

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-12-05
    End date: 2011-12-05

Mylotarg
    Dosage: 6.69 milligram
    Start date: 2012-03-09
    End date: 2012-03-09

Vorinostat
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-12-02
    End date: 2011-12-10

Vidaza
    Dosage: 167 milligram
    Start date: 2012-03-02
    End date: 2012-03-08

Mylotarg
    Dosage: 6.69 milligram
    Start date: 2012-02-10
    End date: 2012-02-10

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-12-02
    End date: 2011-12-08

Mylotarg
    Dosage: 6.75 milligram
    Start date: 2012-02-06
    End date: 2012-02-06

Mylotarg
    Dosage: 6.69 milligram
    Start date: 2012-03-05
    End date: 2012-03-05

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-12-30
    End date: 2011-12-30

Vorinostat
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-12-23
    End date: 2011-12-31

Vorinostat
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2012-02-03
    End date: 2012-02-11

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-12-23
    End date: 2011-12-29

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2012-02-03
    End date: 2012-02-09

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-12-09
    End date: 2011-12-09

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-12-26
    End date: 2011-12-26

Other drugs received by patient: Hydrocortisone; Diphenhydramine HCL; Diphenhydramine HCL; Acetaminophen; RED Cell; Hydrocortisone; Claritin; Platelets; Ativan; Metformin HCL; Hydrocortisone; Protonix; Compazine; Hydrocortisone; Cozaar; Hydrocortisone; Diphenhydramine HCL; Diphenhydramine HCL; Acetaminophen; Acetaminophen; Prochlorperazine; Actos; Acetaminophen

Possible Mylotarg side effects in male

Reported by a consumer/non-health professional from United Kingdom on 2012-04-02

Patient: male

Reactions: Renal Impairment, Intravascular Haemolysis, Clostridium Difficile Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evoltra
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2009-04-25

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2009-04-25

Mylotarg
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2009-04-25

Possible Mylotarg side effects in male

Reported by a physician from United States on 2012-03-29

Patient: male

Reactions: Adverse Drug Reaction, Perirectal Abscess

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 6.75 milligram
    Start date: 2012-02-06
    End date: 2012-02-06

Vidaza
    Dosage: 167 milligram
    Start date: 2012-03-02
    End date: 2012-03-08

Mylotarg
    Dosage: 6.69 milligram
    Start date: 2012-03-09
    End date: 2012-03-09

Vidaza
    Dosage: 169 milligram
    Start date: 2012-02-03
    End date: 2012-02-09

Mylotarg
    Dosage: 6.75 milligram
    Start date: 2012-02-10
    End date: 2012-02-10

Vorinostat
    Dosage: 400
    Administration route: Oral
    Start date: 2012-02-03
    End date: 2012-02-11

Vorinostat
    Dosage: 400
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-10

Mylotarg
    Dosage: 6.69 milligram
    Start date: 2012-03-05
    End date: 2012-03-05

Other drugs received by patient: Actos; Ativan; RED Cell; Platelets; Compazine; Claritin; Metformin HCL; Cozaar; Protonix

Possible Mylotarg side effects in male

Reported by a individual with unspecified qualification from United States on 2012-03-13

Patient: male, weighing 15.7 kg (34.5 pounds)

Reactions: Cardiac Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 15510 mg

Etoposide
    Dosage: 585 mg

Mitoxantrone Hydrochloride
    Dosage: 16.4 mg

Mylotarg
    Dosage: 2 mg

Elspar
    Dosage: 4120 iu

Daunorubicin HCL
    Dosage: 100.5 mg

Other drugs received by patient: Mitoxantrone; Doxorubicin HCL; Fludarabine Phosphate; Busulfan

Possible Mylotarg side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-12

Patient: 60 year old female, weighing 75.1 kg (165.2 pounds)

Reactions: Sepsis, Acute Myeloid Leukaemia, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-09-03

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-09-03

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-09-07
    End date: 2011-09-07

Other drugs received by patient: Oxycodone HCL; Ondansetron; Loratadine; Allopurinol; Diphenhydramine HCL; Lorazepam; Insulin; Albuterol; Metoclopramide; Metronidazole; Vancomycin; Meropenem; Chlorhexidine Gluconate; Omeprazole; Acyclovir; Acetaminophen; Meperidine HCL; Lidocaine / Diphenhydra / AL-MG Hydrox; Prochlorperazine; Voriconazole

Possible Mylotarg side effects in 74 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07

Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Multi-Organ Failure, Sepsis, Febrile Neutropenia, Atrial Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-11-22
    End date: 2011-11-22

Azacitidine
    Dosage: 160 milligram
    Start date: 2011-11-15
    End date: 2011-11-21

Possible Mylotarg side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-28

Patient: 66 year old female, weighing 64.9 kg (142.8 pounds)

Reactions: White Blood Cell Count Decreased, Cardiac Failure, Injection Site Reaction, Febrile Neutropenia, Pleural Effusion, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-11

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-10

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-10-04
    End date: 2011-10-12

Other drugs received by patient: Levothyroxine Sodium; Lipitor; Diphenhydramine HCL; Hydrocodone

Possible Mylotarg side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14

Patient: 56 year old female, weighing 60.9 kg (133.9 pounds)

Reactions: Supraventricular Tachycardia, Pneumothorax, Pyrexia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-07
    End date: 2011-11-13

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-11-07
    End date: 2011-11-13

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-11-10
    End date: 2011-11-10

Other drugs received by patient: Levofloxacin; Acetaminophen; Aluminum-Magnesium-Simethicone; Magnesium Hydroxide TAB; Docusate; Vitamin D; Riboflavin; Chlorhexidine Gluconate; Hypromellose; Lorazepam; Oxycodone HCL; Magnesium Citrate; Eucerin; Miralax; Morphine; Acyclovir; Albuterol; Senna; Omeprazole; Benadryl; Dalteparin Sodium; Loperamide HCL; Multi-Vitamins; Ascorbic Acid; Fluconazole; Ipratropium Bromide; Lanolin; Metoclopramide; Zofran; Benadryl; Prednisone TAB; Lorazepam; Metoclopramide; Prochlorperazine

Possible Mylotarg side effects in 74 year old male

Reported by a physician from United States on 2012-02-10

Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Multi-Organ Failure, Sepsis, Febrile Neutropenia, Atrial Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 3 mg/m2 over 2 hours on day 8
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-22
    End date: 2011-11-22

Azacitidine
    Dosage: 75 mg/m2 on days 1-7, 160 mg per day
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-15
    End date: 2011-11-21

Possible Mylotarg side effects in 60 year old female

Reported by a physician from United States on 2012-02-07

Patient: 60 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Acute Myeloid Leukaemia, Sepsis, Febrile Neutropenia, Pyrexia, Disease Progression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 75 mg/m2, sc or iv on days 1-7
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-09-03

Mylotarg
    Dosage: 3 mg/m2, on days 4 and 8
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-09-07
    End date: 2011-09-07

Zolinza
    Dosage: 400 mg, on days 1-9
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-09-03

Other drugs received by patient: Acyclovir; Insulin; Oxycodone; Omeprazole; Meperidine HCL; Allopurinol; Aluminium Hydroxide / Diphenhydramine / Magnesium Hydroxide / Lidocaine; Acetaminophen; Chlorhexidine Gluconate; Albuterol; Loratadine; Ondansetron; Diphenhydramine; Lorazepam; Metoclopramide; Prochlorperazine

Possible Mylotarg side effects in 65 year old male

Reported by a physician from United States on 2012-01-26

Patient: 65 year old male, weighing 70.0 kg (153.9 pounds)

Reactions: Respiratory Failure, Sepsis, Febrile Neutropenia, Pneumonitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-08-23

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-10-25
    End date: 2011-10-31

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-10-25
    End date: 2011-11-02

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-08-23

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-08-23

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-25
    End date: 2011-10-30

Possible Mylotarg side effects in 56 year old female

Reported by a physician from United States on 2012-01-26

Patient: 56 year old female, weighing 60.8 kg (133.8 pounds)

Reactions: Supraventricular Tachycardia, Pneumothorax, Pyrexia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 mg, on days 1-9
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-13

Mylotarg
    Dosage: 3 mg/m2, on days 4 and 8
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-10
    End date: 2011-11-10

Vidaza
    Dosage: 75 mg/m2/day on days 1-7
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-13

Other drugs received by patient: Ascorbic Acid; Lanolin; Prednisone; Morphine; Multi-Vitamins; Miralax; Ipratropium; Magnesium Hydroxide; Prochlorperazine; Eucerin; Ondansetron HCL; Loperamide; Chlorhexidine Gluconate; Dalteparin Sodium; Docusate; Metoprolol; Levofloxacin; Omeprazole; Lorazepam; Oxycodone; Senna; Benadryl; Albuterol; Acetaminophen; Vitamin D; Acyclovir; Benadryl; Fluconazole; Aluminum Phosphate Gel / Magnesium Hydroxide / Simethicone; Hypromellose; Lorazepam; Metoclopramide; Magnesium Citrate

Possible Mylotarg side effects in 66 year old female

Reported by a physician from United States on 2012-01-26

Patient: 66 year old female, weighing 64.9 kg (142.8 pounds)

Reactions: White Blood Cell Count Decreased, Cardiac Failure, Injection Site Reaction, Febrile Neutropenia, Pleural Effusion, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 mg, on days 1-9
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-04
    End date: 2011-10-12

Mylotarg
    Dosage: 3 mg/m2, on days 4 and 8
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-04
    End date: 2011-10-11

Vidaza
    Dosage: 75 mg/m2, on days 1-7
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-04
    End date: 2011-10-10

Other drugs received by patient: Hydrocodone; Lipitor; Benadryl; Levothyroxine Sodium

Possible Mylotarg side effects in 74 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13

Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Multi-Organ Failure, Sepsis, Febrile Neutropenia, Atrial Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azacitidine
    Dosage: 75 milligram/sq. meter
    Start date: 2011-11-15
    End date: 2011-11-21

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-11-22
    End date: 2011-11-22

Possible Mylotarg side effects in 74 year old female

Reported by a physician from Italy on 2012-01-09

Patient: 74 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Thrombocytopenia, Cerebral Haemorrhage

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Mylotarg
    Dosage: 5 mg, single
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-10-20
    End date: 2010-10-20

Mylotarg
    Dosage: 5 mg, single
    Start date: 2010-10-27
    End date: 2010-10-27

Possible Mylotarg side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-06

Patient: 56 year old female, weighing 60.9 kg (133.9 pounds)

Reactions: Supraventricular Tachycardia, Pneumothorax, Pyrexia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-11-07
    End date: 2011-11-13

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-07
    End date: 2011-11-13

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-11-10
    End date: 2011-11-10

Possible Mylotarg side effects in 74 year old male

Reported by a physician from United States on 2011-12-28

Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Multi-Organ Failure, Sepsis, Atrial Fibrillation, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 3 mg/m2 over 2 hours on day 8, total dose administered this course 6.45mg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-22
    End date: 2011-11-22

Azacitidine
    Dosage: 75mg/m2 on days 1-7, 160mg per day, total dose administered this course 1121mg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-15
    End date: 2011-11-21

Possible Mylotarg side effects in 74 year old male

Reported by a physician from United States on 2011-12-28

Patient: 74 year old male, weighing 126.0 kg (277.2 pounds)

Reactions: Diarrhoea, Dehydration, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vidaza
    Dosage: 75 mg/m2/day sc or iv on days 1-7
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-19

Vidaza
    Dosage: 75 mg/m2/day sc or iv on days 1-7
    Start date: 2011-10-25

Zolinza
    Dosage: 400 mg 1x/day on days 1-9
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-19

Mylotarg
    Dosage: 3 mg/m2 over 2 hours on days 4 and 8
    Start date: 2011-10-25

Zolinza
    Dosage: 400 mg 1x/day on days 1-9
    Administration route: Oral
    Start date: 2011-10-25

Mylotarg
    Dosage: 3 mg/m2 over 2 hours on days 4 and 8
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-19

Possible Mylotarg side effects in 74 year old male

Reported by a physician from United States on 2011-12-27

Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Vomiting, Dyspnoea, Nausea, Tachycardia, Febrile Neutropenia, Atrial Fibrillation, Multi-Organ Failure, Sepsis, Tachypnoea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azacitidine
    Dosage: 75mg/m2 on days 1-7, 160mg per day, total dose administered this course 1121mg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-15
    End date: 2011-11-21

Mylotarg
    Dosage: 3 mg/m2 over 2 hours on day 8, total dose administered this course 6.45mg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-22
    End date: 2011-11-22

Possible Mylotarg side effects in 74 year old male

Reported by a physician from United States on 2011-12-21

Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Sepsis, Febrile Neutropenia, Atrial Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azacitidine
    Dosage: 75mg/m2 on days 1-7, 160mg per day, total dose administered this course 1121mg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-15
    End date: 2011-11-21

Mylotarg
    Dosage: 3 mg/m2 over 2 hours on day 8, total dose administered this course 6.45mg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-22
    End date: 2011-11-22